There are still lots of open positions. Let's find the one that's right for you.
Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. We are seeking a highly motivated, experienced, and passionate individual to join our team as Associate Director, Pharmacovigilance at Ardelyx Inc. As a subject matter expert, you will play a pivotal role in ensuring the adherence of our pharmacovigilance (PV) activities to regulatory requirements, industry standards, company policies, and global regulations. In this role, you will be responsible for ensuring the highest quality of pharmacovigilance operations and safety outputs and analysis in compliance with global regulations and standards.